Core Viewpoint - Mediwake (02159) reported a net loss attributable to shareholders of 6.123 million yuan for the first half of 2025, a significant reduction of 72.4% year-on-year, despite a revenue decline of 9.7% to 127 million yuan [1][1][1] Financial Performance - Revenue for the first half of 2025 was 127 million yuan, representing a year-on-year decrease of 9.7% [1] - The net loss attributable to shareholders was 6.123 million yuan, which is a 72.4% reduction compared to the previous year [1] - Basic loss per share was 3.20 cents [1] Profitability Metrics - The overall gross profit margin increased from 14.7% for the six months ending June 30, 2024, to 17.1% in the reporting period [1] - The improvement in gross profit margin is attributed to the company's strategic focus on higher-margin projects [1]
麦迪卫康(02159)发布中期业绩，股东应占亏损612.3万元，同比收窄72.4%